Deviation of nasal septum
Conditions
Interventions
dexmedetomidine group:dexmedetomidine 0.5ug/kg
Nalbuphine combined with dexmedetomidine group:Nalbuphine0.2mg/kg and dexmedetomidine 0.5ug/kg
control group:none
Sponsors
Huai 'an Second People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. ASA I - II subjects; 2. Patients aged from 18 to 65 years old who would like to receive nasal septum deviation correction under general anesthesia and nasal endoscopy.
Exclusion criteria
Exclusion criteria: 1. Patients taking long-term analgesics or cortisol drugs; 2. Patients with bradycardia; atrioventricular block; 3. Patients with uncontrolled hypertension, heart, liver, kidney and other serious diseases; 4. Patients with endocrine and metabolic diseases; 5. Patients with nervous system diseases; 6. Patients with mental or neurological diseases; 7. Subjects with alcohol addiction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NRS;MAP;heart rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse reactions;extubation and wake time;Dosage of narcotic drugs; | — |
Countries
China
Contacts
Public ContactJun Wang
Huai 'an Second People's Hospital
Outcome results
None listed